Listen COCKROACH..I've ben at this game for over TWO decades and know the game well. If you think for a second you and all the other "new aliases" who popped up on this board over the past 8 weeks are "clever" to people in my league...you're a fool. Is Johnny ordering CHINESE FOOD for you dolts IN today so you can hammer on those computers while you stuff your faces with MSG and Calico cat? LMAO
You fools have absolutely no clue who I am. I know where she is going to land 'cause I know where the HF wants it. This next trade will be another winner :-)
Hi nomad - was checking your posts before and after the fall. You clearly know the game here. I don't. Not being a biotech expert i was indeed surprised at the 1bl market cap (pretty usual here for a biotech) but for such a small expected revenue and huge (i mean huge) debt (north of the usuals in biotech). My life insurance is full and 10% profit is not what i'm after. I'm ready to loose some money on a biotech as it's apparently the next big thing.
A friend recently recommended this company: Please could you have a look when you have time at Provectus Pharma. Pvct. They are waiting for Spa recipient (at any time apparently..), NO DEBT, money in the bank (but probably not enough for a full phase3 trial), market cap of 70M (with a market cap target amongst investors and the board of 1Bln). Pipes: Melanoma cancer, derm. Management over-pays itself but data seems exceptional, if not hard-to-believe...Thanks much for your views on this company and market. Kind regards Laurence, Paris, France.